Target
Guanylate cyclase soluble subunit alpha-1
Ligand
BDBM463287
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
1.57±n/a nM
Citation
 Whitehead, AOrnoski, ORaghavan, SBerger, RGarfunkle, JYang, ZJi, GJiang, FFu, J Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators US Patent  US10780092 Publication Date 9/22/2020 
Target
Name:
Guanylate cyclase soluble subunit alpha-1
Synonyms:
GCS-alpha-1 | GCS-alpha-3 | GCYA1_HUMAN | GUC1A3 | GUCSA3 | GUCY1A1 | GUCY1A3 | Guanylate cyclase soluble (GCS-alpha-1) | Guanylate cyclase soluble subunit alpha-3 | Solube guanylate cyclase alpha-1 (sGC alpha-1) | Solube guanylate cyclase alpha-1 (sGCalpha) | soluble guanylate cyclase alpha-1 (sGC)
Type:
Enzyme
Mol. Mass.:
77457.21
Organism:
Homo sapiens (Human)
Description:
Q02108
Residue:
690
Sequence:
MFCTKLKDLKITGECPFSLLAPGQVPNESSEEAAGSSESCKATVPICQDIPEKNIQESLPQRKTSRSRVYLHTLAESICKLIFPEFERLNVALQRTLAKHKIKESRKSLEREDFEKTIAEQAVAAGVPVEVIKESLGEEVFKICYEEDENILGVVGGTLKDFLNSFSTLLKQSSHCQEAGKRGRLEDASILCLDKEDDFLHVYYFFPKRTTSLILPGIIKAAAHVLYETEVEVSLMPPCFHNDCSEFVNQPYLLYSVHMKSTKPSLSPSKPQSSLVIPTSLFCKTFPFHFMFDKDMTILQFGNGIRRLMNRRDFQGKPNFEEYFEILTPKINQTFSGIMTMLNMQFVVRVRRWDNSVKKSSRVMDLKGQMIYIVESSAILFLGSPCVDRLEDFTGRGLYLSDIPIHNALRDVVLIGEQARAQDGLKKRLGKLKATLEQAHQALEEEKKKTVDLLCSIFPCEVAQQLWQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPGFVFTPRSREELPPNFPSEIPGICHFLDAYQQGTNSKPCFQKKDVEDGNANFLGKASGID
  
Inhibitor
Name:
BDBM463287
Synonyms:
5-(4-Chloro-3-hydroxy- phenyl)-4-(4,4-difluoro- piperidin-1-yl)-2-{8-[(4- fluorophenyl)methyl]- imidazo[1,2-a]pyrazin-6- yl}-5-methyl-5,7-dihydro- 6H-pyrrolo[2,3-d]- pyrimidin-6-one | US10780092, Example 136-A
Type:
Small organic molecule
Emp. Form.:
C31H25ClF3N7O2
Mol. Mass.:
620.024
SMILES:
CC1(C(=O)Nc2nc(nc(N3CCC(F)(F)CC3)c12)-c1cn2ccnc2c(Cc2ccc(F)cc2)n1)c1ccc(Cl)c(O)c1
Structure:
Search PDB for entries with ligand similarity: